Hyper-CVAD
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hyper-CVAD, covering 2013-09-25 to 2015-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia [Phase 2]